2,3,6,7-Tetrahydrobenzo[1,2-b:4,5-b']difuran

Catalog No.: 
ACVXBA963
CAS No.: 
81926-24-1
Molecular Formula: 
C10H10O2
Molecular Weight: 
162.19
2,3,6,7-Tetrahydrobenzo[1,2-b:4,5-b']difuran structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$58.00In stockIn stock
10g97%$99.00In stockIn stock
25g97%$204.00In stockIn stock
100g97%$666.00InquiryInquiry
500g97%$2424.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,3,6,7-Tetrahydrobenzo[1,2-b:4,5-b']difuran
IUPAC Name2,3,6,7-tetrahydrobenzo[1,2-b:4,5-b']difuran
MDL No.MFCD08436969
Molecular FormulaC10H10O2
Molecular Weight162.19
SMILESC1(OCCC1=C2)=CC3=C2OCC3
InChI KeyYQBBCPKSALSCAP-UHFFFAOYSA-N
Synonym2,3,6,7-tetrahydrofuro[2,3-f][1]benzofuran;2,3,6,7-Tetrahydro-benzo[1,2-b;2,3,6,7-Tetrahydrobenzo[1,2-B:4,5-B']Furan;Benzo[1,2-b:4,5-b']difuran,2,3,6,7-tetrahydro-;5-b]difuran;7-Tetrahydro-benzo[1;4,10-dioxatricyclo[7.3.0.0,3,7]dodeca-1,3(7),8-triene;SKL124
CAS No.81926-24-1
PubChem CID10986562

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVXBA963 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVXBA963 route product structure diagram
    ACVXBA96381926-24-1In Stock
Inquiry

2. ACVXBA963 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVXBA963 route product structure diagram
    ACVXBA96381926-24-1In Stock
Inquiry

3. ACVXBA963 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVXBA963 route product structure diagram
    ACVXBA96381926-24-1In Stock
Inquiry

Comments (0)